fbpx

Archives August 2019

Community Education Group's Founder and Executive Director speaking on a panel at a meeting in Mexico City in 2019

Una Conversación Communitaria: Cura y Más de VIH (A Community Conversation: HIV Cure & More)

As part of the lead-up to the 2019 International AIDS Society (IAS) conference in Mexico City, CEG collaborated with local NGO partners Casa de la Sal and Clínica Especializada Condesa, as well as Mexico’s Centro de Investigación en Enfermedades Infecciosas (CIENI) and the Washington DC-based Martin Delany Collaboratory (MDC) BELIEVE program, to present a two-day pre-conference event on July 18-19, 2019. Hosting more than 300 attendees, Una Conversación Communitaria brought local people living with HIV/AIDS, NGO workers, students, and public health professionals who might otherwise have been unable to experience IAS 2019 together with international researchers, scientists, academics, and community organizations offering global learning opportunities. The event also helped ensure that the voices of the Mexican people could still be included in the international dialogue about HIV/AIDS, at a time when the Mexican government has cut back the resources available to local NGOs. Podcast of the event is available here.

Harm Reduction in West Virginia’s Eastern Panhandle

Responding to CDC reports about a spike in Hepatitis C infections across numerous West Virginia counties, and thanks to a grant from the Harm Reduction Coalition’s HEPConnect Initiative, CEG is currently working in collaboration with the Exchange Union to expand harm reduction services in West Virginia’s Eastern Panhandle. West Virginia leads the U.S. in opioid and drug overdose deaths, a trend that is not only troubling in itself but also because injection drug use and substance abuse are key drivers for communicable disease. With more than half of the state’s counties at high risk for Hep C and HIV, CEG’s goal is to get out in front of the problem before it reaches epidemic proportions by expanding the state’s focus beyond opioid death reduction and abstinence-only chemical dependency programs, to include safe syringe programs and linkage to care.